Global Stock News

Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans

Article feature image

Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you’d have…

Click here to view the original article.

Share this article

Scroll to Top